The studies described in this application will utilize FcepsilonRI as a model system for antigen receptor mediated cell activation. The attractiveness of FcepsilonRI as a model system is due in particular to three features: 1) the complete multi-subunit receptor can be studied using currently available molecular techniques; 2) its rapid engagement and disengagement capability permits the analysis of both positive and negative regulations of kinase-dependent signaling pathways; 3) homogenous FcepsilonRI+ cell populations can be easily generated from the rapidly expanding repertoire of mice with targeted inactivations of signal transduction proteins. Utilizing these features specific to FcepsilonRI, several intriguing questions about antigen receptor signaling can be answered: 1) Is a multi-subunit receptor more than the sum of its parts? Two signaling chains of FcepsilonRI (the beta and gamma subunits) participate cooperatively to amplify FcepsilonRI- mediated signals. The experiments proposed will analyze how interactions among the beta and gamma subunits and two tyrosine kinases produce a signal amplifier. 2) How is antigen receptor signaling controlled? A specific negative regulatory molecule - hematopoietic cell phosphatase, and its interactions with FcepsilonRI alone and in conjunction with an inhibitory antigen receptor will be analyzed. 3) How are NRTKs which don't interact directly with an antigen receptor controlled by antigen receptor clustering? A model of btk kinase activation by the src family kinase lyn will be tested and the data used to understand how FcepsilonRI clustering initiates the events leading to btk activation and interaction with downstream effectors. 4) How do antigen receptors mobilize calcium? FcepsilonRI is shown to activate a sphingosine kinase (SK) pathway for calcium mobilization. Experiments are proposed to analyze how FcepsilonRI is linked to SK activation. The answers to these questions will provide a molecular dissection of FcepsilonRI function which will be relevant to the understanding of other multi-subunit antigen receptors.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM053950-03
Application #
2685099
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1996-04-01
Project End
2000-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Vig, Monika; Kinet, Jean-Pierre (2009) Calcium signaling in immune cells. Nat Immunol 10:21-7
Vig, Monika; DeHaven, Wayne I; Bird, Gary S et al. (2008) Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat Immunol 9:89-96
Vig, Monika; Beck, Andreas; Billingsley, James M et al. (2006) CRACM1 multimers form the ion-selective pore of the CRAC channel. Curr Biol 16:2073-9
On, Marina; Billingsley, James M; Jouvin, Marie-Helene et al. (2004) Molecular dissection of the FcRbeta signaling amplifier. J Biol Chem 279:45782-90
Lantz, C S; Yamaguchi, M; Oettgen, H C et al. (1997) IgE regulates mouse basophil Fc epsilon RI expression in vivo. J Immunol 158:2517-21
Yamaguchi, M; Lantz, C S; Oettgen, H C et al. (1997) IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 185:663-72
Fleming, T J; Donnadieu, E; Song, C H et al. (1997) Negative regulation of Fc epsilon RI-mediated degranulation by CD81. J Exp Med 186:1307-14
Dombrowicz, D; Flamand, V; Miyajima, I et al. (1997) Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J Clin Invest 99:915-25